DHX9-IN-4
DHX9-IN-4 (Compound 609) is an ATP-dependent inhibitor of RNA helicase A (DHX9) with potential for cancer research[1].
Product Specifications
CAS Number
2973401-45-3
UNSPSC
12352005
Target
DNA/RNA Synthesis
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/dhx9-in-4.html
Purity
98.54
Solubility
DMSO : 12.5 mg/mL (ultrasonic; warming; heat to 60°C)
Smiles
O=C(C1=CC(C2=NC=C(C=N2)OC3CN(C3)C)=C(C)S1)NC4=CC(Cl)=CC(NS(=O)(C)=O)=C4
Molecular Formula
C21H22ClN5O4S2
Molecular Weight
508.01
References & Citations
[1]DANIELS Matthew H., et al. Preparation of imidazopyridines, thienopyrimidines, pyrrolopyrimidines and related heterocycles as inhibitors of RNA helicase DHX9 useful in treatment of cancers. World Intellectual Property Organization, WO2023154519 A1 2023-08-17
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS6326141-01 0.2 mL
NOXO1, ID (NOXO1, P41NOX, SH3PXD5, NADPH oxidase organizer 1, NADPH oxidase regulatory protein, Nox organizer 1, Nox-organizing protein 1, SH3 and PX domain-containing protein 5) (FITC)
Sign In for Pricing
View Details MBS6326141-02 5x 0.2 mL
NOXO1, ID (NOXO1, P41NOX, SH3PXD5, NADPH oxidase organizer 1, NADPH oxidase regulatory protein, Nox organizer 1, Nox-organizing protein 1, SH3 and PX domain-containing protein 5) (FITC)
Sign In for Pricing
View Details BNC880242-100 1x 100 µL
PTH / Parathyroid Hormone (N-Terminal) (3H9), CF488A conjugate, 0.1mg/mL
Sign In for Pricing
View Details 